HEPION PHARMACEUTICALS, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
HEPION PHARMACEUTICALS, INC. (HEPA) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $3.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2024-04-16
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-12-31 was $3.20M.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-06-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2023-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $3.20M.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $0.00.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2021 was $0.00.
- HEPION PHARMACEUTICALS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2020 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $3.20M derived: sum of 2 quarters · filed 2024-04-16 | $3.20M derived: sum of 3 quarters · filed 2024-04-16 | $3.20M 10-K · filed 2024-04-16 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 10-Q · filed 2023-11-20 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $0.00 10-Q · filed 2023-11-20 | $0.00 derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | $0.00 derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | $0.00 derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $0.00 derived: sum of 2 quarters · filed 2023-04-10 | $0.00 derived: sum of 3 quarters · filed 2023-04-10 | $0.00 10-K · filed 2023-04-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2022-08-15 | $0.00 derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-16 | $0.00 derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $0.00 derived: sum of 3 quarters · filed 2022-04-08 | $0.00 10-K · filed 2022-04-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-08-16 | $0.00 derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 derived: sum of 3 quarters · filed 2021-05-14 | $0.00 derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-06-29 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |